bullish

Hang Seng Index (HSI) Rebalance: Innovent Biologics Turns a Profit, Gets Added

565 Views24 Nov 2025 05:18
Innovent Bio is an add in Dec. Estimated one-way turnover is 2.3% and round-trip trade is HK$9.2bn. Innovent Bio has also been added to the HSCEI, and the double inclusion could be a short-term boost.
What is covered in the Full Insight:
  • Introduction
  • Innovent Biologics' Addition to Indexes
  • Market Implications of Index Rebalance
  • Impact on Related Industries and Companies
  • Conclusion
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 4-minute read)
Discussions
(Paid Plans Only)
chart-bar
x